Profound Medical (PROF) Cash & Current Investments (2018 - 2026)

Profound Medical has reported Cash & Current Investments for 9 years, with the latest figure at $50.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 8.32% year-over-year to $50.3 million; the trailing twelve-month figure through Mar 2026 stood at $50.3 million (up 8.32% YoY), and the FY2025 full-year result was $59.7 million, up 8.76% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $50.3 million, down from $59.7 million in the prior quarter.
• The five-year high for Cash & Current Investments was $67.2 million in Q3 2022, with the low at $24.8 million in Q3 2025.
• Average Cash & Current Investments over 5 years is $46.2 million, with a median of $46.5 million recorded in 2022.
• Year-over-year, Cash & Current Investments slumped 49.94% in 2023 and jumped 109.48% in 2024.
• Tracing PROF's Cash & Current Investments over 5 years: stood at $46.5 million in 2022, then tumbled by 43.65% to $26.2 million in 2023, then surged by 109.48% to $54.9 million in 2024, then grew by 8.76% to $59.7 million in 2025, then fell by 15.79% to $50.3 million in 2026.
• The last three Cash & Current Investments figures came in at $50.3 million (Q1 2026), $59.7 million (Q4 2025), and $24.8 million (Q3 2025), per Business Quant data.

Peer Comparison